Literature DB >> 14999075

Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice.

Dana M Shin1, Sailaja Korada, Rossana Raballo, Cooduvalli S Shashikant, Antonio Simeone, Jane R Taylor, Flora Vaccarino.   

Abstract

Fibroblast growth factor receptor (FGFR) gene products (Fgfr1, Fgfr2, Fgfr3) are widely expressed by embryonic neural progenitor cells throughout the CNS, yet their functional role in cerebral cortical development is still unclear. To understand whether the FGF pathways play a role in cortical development, we attenuated FGFR signaling by expressing a tyrosine kinase domain-deficient Fgfr1 (tFgfr1) gene construct during embryonic brain development. Mice carrying the tFgfr1 transgene under the control of the Otx1 gene promoter have decreased thickness of the cerebral cortex in frontal and temporal areas because of decreased number of pyramidal neurons and disorganization of pyramidal cell dendritic architecture. These alterations may be, in part, attributable to decreased genesis of T-Brain-1-positive early glutamatergic neurons and, in part, to a failure to maintain radial glia fibers in medial prefrontal and temporal areas of the cortical plate. No changes were detected in cortical GABAergic interneurons, including Cajal-Retzius cells or in the basal ganglia. Behaviorally, tFgfr1 transgenic mice displayed spontaneous and persistent locomotor hyperactivity that apparently was not attributable to alterations in subcortical monoaminergic systems, because transgenic animals responded to both amphetamine and guanfacine, an alpha2A adrenergic receptor agonist. We conclude that FGF tyrosine kinase signaling may be required for the genesis and growth of pyramidal neurons in frontal and temporal cortical areas, and that alterations in cortical development attributable to disrupted FGF signaling are critical for the inhibitory regulation of motor behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999075      PMCID: PMC6730438          DOI: 10.1523/JNEUROSCI.5285-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

Review 1.  Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders.

Authors:  John L R Rubenstein
Journal:  J Child Psychol Psychiatry       Date:  2010-08-24       Impact factor: 8.982

2.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.

Authors:  Dhruba J Bharali; Ilona Klejbor; Ewa K Stachowiak; Purnendu Dutta; Indrajit Roy; Navjot Kaur; Earl J Bergey; Paras N Prasad; Michal K Stachowiak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 3.  Fibroblast growth factors in schizophrenia.

Authors:  Afke F Terwisscha van Scheltinga; Steven C Bakker; René S Kahn
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

Review 4.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

5.  Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia.

Authors:  Devon M Fagel; Yosif Ganat; Elise Cheng; John Silbereis; Yasushi Ohkubo; Laura R Ment; Flora M Vaccarino
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

6.  Canonical transient receptor potential 1 plays a role in basic fibroblast growth factor (bFGF)/FGF receptor-1-induced Ca2+ entry and embryonic rat neural stem cell proliferation.

Authors:  Alessandra Fiorio Pla; Dragan Maric; So-Ching Brazer; Paolo Giacobini; Xibao Liu; Yoong Hee Chang; Indu S Ambudkar; Jeffery L Barker
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

7.  Genomic characterisation of a Fgf-regulated gradient-based neocortical protomap.

Authors:  Stephen N Sansom; Jean M Hébert; Uruporn Thammongkol; James Smith; Grace Nisbet; M Azim Surani; Susan K McConnell; Frederick J Livesey
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

Review 8.  Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism.

Authors:  Flora M Vaccarino; Elena L Grigorenko; Karen Müller Smith; Hanna E Stevens
Journal:  J Autism Dev Disord       Date:  2008-10-13

Review 9.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

10.  Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse.

Authors:  Yasushi Ohkubo; Ayumi O Uchida; Dana Shin; Juha Partanen; Flora M Vaccarino
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.